254 related articles for article (PubMed ID: 30554492)
1. Antithrombotic Medication and the Risk of Vitreous Hemorrhage in Atrial Fibrillation: Korean National Health Insurance Service National Cohort.
Kim KE; Yang PS; Jang E; Kim S; Joung B
Yonsei Med J; 2019 Jan; 60(1):65-72. PubMed ID: 30554492
[TBL] [Abstract][Full Text] [Related]
2. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS
Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
[TBL] [Abstract][Full Text] [Related]
4. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
[TBL] [Abstract][Full Text] [Related]
5. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
Guo Y; Wang H; Tian Y; Wang Y; Lip GYH
Chest; 2015 Jul; 148(1):62-72. PubMed ID: 25501045
[TBL] [Abstract][Full Text] [Related]
6. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
[TBL] [Abstract][Full Text] [Related]
7. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
8. [Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study].
Zhu LY; Li Q; Yu LY; Liu Y; Chen YN; Wang Z; Zhang SY; Li J; Liu Y; Zhao YL; Xi Y; Pi L; Sun YH
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):731-741. PubMed ID: 37460427
[No Abstract] [Full Text] [Related]
9. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
[TBL] [Abstract][Full Text] [Related]
10. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
Thompson PL; Verheugt FW
Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
[TBL] [Abstract][Full Text] [Related]
11. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients.
Shireman TI; Howard PA; Kresowik TF; Ellerbeck EF
Stroke; 2004 Oct; 35(10):2362-7. PubMed ID: 15331796
[TBL] [Abstract][Full Text] [Related]
12. Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Nationwide Population-Based Study.
Yoon CY; Noh J; Jhee JH; Chang TI; Kang EW; Kee YK; Kim H; Park S; Yun HR; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Kim C; Yoo TH
Stroke; 2017 Sep; 48(9):2472-2479. PubMed ID: 28801476
[TBL] [Abstract][Full Text] [Related]
13. Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?
Kuo L; Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645935
[TBL] [Abstract][Full Text] [Related]
14. Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy.
van Rein N; Heide-Jørgensen U; Lijfering WM; Dekkers OM; Sørensen HT; Cannegieter SC
Circulation; 2019 Feb; 139(6):775-786. PubMed ID: 30586754
[TBL] [Abstract][Full Text] [Related]
15. Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention.
Chi G; Yee MK; Kalayci A; Kerneis M; AlKhalfan F; Mehran R; Bode C; Halperin JL; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Cohen M; Peterson ED; Fox KAA; Gibson CM
J Thromb Thrombolysis; 2018 Oct; 46(3):346-350. PubMed ID: 29943350
[TBL] [Abstract][Full Text] [Related]
16. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
[TBL] [Abstract][Full Text] [Related]
17. [Impact of different antithrombotic therapy strategy on prognosis in coronary heart disease patients combining with atrial fibrillation: a meta analysis].
Yuan C; Zhong L; Huang RC
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jun; 45(6):526-535. PubMed ID: 28648031
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
Larsen TB; Rasmussen LH; Skjøth F; Due KM; Callréus T; Rosenzweig M; Lip GY
J Am Coll Cardiol; 2013 Jun; 61(22):2264-73. PubMed ID: 23562920
[TBL] [Abstract][Full Text] [Related]
19. Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy.
Fosbol EL; Wang TY; Li S; Piccini J; Lopes RD; Mills RM; Klaskala W; Thomas L; Roe MT; Peterson ED
Am Heart J; 2013 Nov; 166(5):864-70. PubMed ID: 24176442
[TBL] [Abstract][Full Text] [Related]
20. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.
Nielsen PB; Larsen TB; Skjøth F; Lip GY
JAMA Intern Med; 2017 Apr; 177(4):563-570. PubMed ID: 28241151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
